Key Metrics Every Healthcare PM Should Own

TL;DR

Healthcare PMs fail when they track vanity metrics like user logins instead of clinical impact. The only metrics that matter are those tied to patient outcomes, cost reduction, or provider efficiency. Own the numbers that force a CFO to sign a check, not the ones that make a dashboard look busy.

Who This Is For

This is for mid-to-senior product managers at digital health startups or established healthcare orgs with P&L exposure, who’ve hit a wall where leadership dismisses their roadmap because their metrics don’t translate to revenue or risk mitigation. If you’ve ever heard “this is nice, but how does it move the needle?” in a QBR, this is your debrief.

What metrics do healthcare PMs actually get judged on in interviews?

In a Google Health debrief last Q2, the hiring committee killed a candidate who nailed adoption numbers but couldn’t articulate how their feature reduced 30-day readmissions. The judgment wasn’t about their data—it was about their inability to connect product levers to financial or clinical stakes.

Healthcare PM metrics aren’t product metrics. They’re business metrics with a product interface. The CFO cares about per-member-per-month (PMPM) savings, the CMO about HEDIS scores, the COO about claims processing velocity. Your dashboard is irrelevant unless it ladders up to one of these. Not user engagement, but cost avoidance. Not feature usage, but risk stratification accuracy.

The counter-intuitive truth: the best healthcare PMs don’t own the most metrics—they own the fewest, but the most leveraged. A PM at Oscar Health who focused solely on medication adherence (tied to Star Ratings and thus CMS bonuses) carried more weight than one tracking a dozen KPIs no exec could tie to margin.

How do you prioritize healthcare metrics when everything is "important"?

In a UnitedHealth Group HC debate, the VP of Product vetoed a team’s focus on member NPS because it didn’t correlate with medical loss ratio (MLR) improvements. The rule: if the metric doesn’t appear in a payer’s or provider’s annual report, it’s a vanity project.

Prioritization isn’t about volume—it’s about traceability to the money. Start with the org’s economic engine: for payers, it’s MLR and administrative cost ratio; for providers, it’s patient throughput and denials rate; for pharma, it’s script lift and adherence. Reverse-engineer from there. Not top-down from OKRs, but bottom-up from the balance sheet.

The framework: the “Three Layers of Proof.” Layer 1: Does the metric move a financial lever (e.g., reducing avoidable ER visits saves $2K per episode)? Layer 2: Can you A/B test it without violating HIPAA or IRB constraints? Layer 3: Does leadership already have a line item for it in their mental model? If no to any, deprioritize.

What’s the difference between a good and a great healthcare PM metric?

A good metric is specific and measurable. A great one is controversial. At a Flatiron Health debrief, a candidate proposed tracking “oncologist time saved per chart review.” The hiring manager pushed back: “Time saved is useless unless it translates to more patients seen or higher-quality decisions.” The candidate pivoted to “additional patients seen per FTE per day,” which directly tied to revenue.

The litmus test: if your metric can’t be debated in a board room, it’s not strategic. Great healthcare PM metrics force trade-offs. Example: reducing prior authorization denials improves patient access but may increase payer costs. The metric isn’t the denial rate—it’s the net margin impact of denying vs. approving, adjusted for risk.

Not all metrics are created equal. Clinical metrics (e.g., HbA1c reduction) are table stakes. Financial metrics (e.g., cost per diabetic patient per year) are the real game. The best PMs own the intersection: “% of diabetic patients with HbA1c < 8% AND cost per patient below $X.”

How do you handle metrics in regulated environments like HIPAA or FDA?

In a Teladoc hiring loop, a PM candidate lost points for proposing a “patient satisfaction” metric post-telehealth visit without accounting for consent withdrawal rates. HIPAA isn’t just a legal constraint—it’s a product constraint. Your metrics must survive an audit.

The non-negotiable: every metric must be collectable, storable, and analysable without PHI exposure. This means hashed IDs, aggregate-level analysis, and zero direct patient identifiers in your dashboards. The moment you start tracking “Mr. Smith’s adherence,” you’ve violated the first rule of healthcare PM.

The counter-intuitive move: sometimes the best metric is the absence of data. For example, in a mental health app, tracking “sessions completed” is risky (PHI). Tracking “% of users who return within 7 days” (with no PHI) tells you engagement without the liability.

Why do most healthcare PMs pick the wrong metrics?

Most healthcare PMs pick metrics that reflect their last company’s culture, not their current one. A PM from a consumer app background defaults to DAU/MAU. A PM from a clinical background defaults to outcomes. Neither speaks the language of the CFO, who signs off on headcount.

The root cause: misaligned incentives. Engineering wants to ship, clinicians want to heal, and finance wants to save. The PM’s job is to find the metric that satisfies all three without lying to any. At a Cityblock Health all-hands, the CEO shut down a team’s focus on “member activation” because it didn’t account for the cost of outreach. The replacement: “cost per activated member per risk-stratified cohort.”

Not all stakeholders are equal. In healthcare, the payer’s metrics (MLR, Star Ratings) often override the provider’s (throughput, burnout). The PM who ignores this hierarchy will build a beautiful product that no one will pay for.

How do you present healthcare metrics to non-technical leaders?

At a Devoted Health exec review, a PM was grilled for 20 minutes on why their “member engagement” metric didn’t account for seasonality (flu season spikes). The lesson: healthcare metrics are only credible if they control for externalities—epidemiological, regulatory, or economic.

The rule: lead with the dollar, then the story. Start with “This feature reduces avoidable ER visits by 15%, saving $1.2M annually in our Medicare Advantage book.” Then explain the mechanism. Not the other way around. Execs in healthcare don’t have time for narratives—they have time for P&L impacts.

The anti-pattern: the “metric salad.” A slide with adoption, engagement, satisfaction, and outcomes. The exec reaction: “Which one should I believe?” Pick one primary metric, and let the others be supporting evidence. If you can’t decide, neither can they.

Preparation Checklist

Map your product’s levers to at least one of the big three: PMPM savings, HEDIS/Star Ratings, or provider efficiency (RVUs, denials, throughput).
Reverse-engineer your org’s financial model to find where your product’s impact is most leveraged (e.g., a 1% improvement in medication adherence = $X in CMS bonuses).
Identify the 1-2 metrics that would make your CEO cancel every other project to scale yours. If you can’t name them, you’re not ready.
Build a data model that survives HIPAA: no PHI in production analytics, aggregate-only reporting, and audit logs for all access.
Create a “controversy document” for your metric: why it’s debated, who disagrees, and how you’d test it. If there’s no debate, it’s not strategic.
Work through a structured preparation system (the PM Interview Playbook covers healthcare-specific metric frameworks with real payer/provider debrief examples).
Mock a board-level discussion where you defend your metric against a CFO who only cares about margin and a CMO who only cares about outcomes.

Mistakes to Avoid

BAD: Tracking “app opens” as a proxy for patient engagement.
GOOD: Tracking “% of high-risk patients who complete a care gap closure within 30 days,” tied to a HEDIS measure with a known dollar value.

BAD: Assuming clinical outcomes are the only metrics that matter.
GOOD: Pairing HbA1c reduction with the cost per percentage point improvement, including lab costs, provider time, and incentive payments.

BAD: Presenting a metric without a baseline or benchmark.
GOOD: “Our current 30-day readmission rate is 18% (industry avg: 15%). Reducing this by 2% saves $500K annually in penalties.”

FAQ

What’s the one metric every healthcare PM should own?

Own the metric that directly ties your product to the org’s primary revenue or cost lever. For a payer, it’s MLR or Star Ratings. For a provider, it’s denials rate or patient throughput. If you can’t name it, you don’t own a metric—you own a distraction.

How do you know if your metric is strategic?

If your metric can’t be debated in a room with the CFO, CMO, and COO, it’s tactical. Strategic healthcare metrics force trade-offs between cost, quality, and access. Example: “Should we reduce prior auth denials (improving access) if it increases costs by 3%?”

When should you abandon a metric?

Abandon it when it fails the “so what?” test three times. If leadership can’t connect it to a financial or clinical outcome after multiple discussions, it’s noise. In healthcare, every metric must survive the question: “How does this affect the next earnings call or CMS audit?”

Ready to build a real interview prep system?

Get the full PM Interview Prep System →

The book is also available on Amazon Kindle.